ALLMedicine™ Budd-Chiari Syndrome Center
Research & Reviews 379 results
https://doi.org/10.1002/ajh.26896
American Journal of Hematology; Kiladjian JJ, Cassinat B
Mar 5th, 2023 - Myeloproliferative neoplasms (MPNs) are the most common etiologies of primary splanchnic vein thrombosis, present in almost forty percent of patients with Budd-Chiari syndrome or portal vein thrombosis. Diagnosis of MPNs can be difficult in these ...
http://emedicine.medscape.com/article/2172621-overview
Jan 20th, 2023 - SAAG Interpretation The serum ascites albumin gradient (SAAG) is a formula used to assist in determining the etiology of ascites. Also see Medscape’s Ascites Albumin Gradient Calculator. The formula is below. SAAG = serum albumin – ascites albumin...
https://emedicine.medscape.com/article/2172621-print
Jan 20th, 2023 - The serum ascites albumin gradient (SAAG) is a formula used to assist in determining the etiology of ascites. Also see Medscape’s Ascites Albumin Gradient Calculator. The formula is below. SAAG = serum albumin – ascites albumin A high gradient (SA...
https://emedicine.medscape.com/article/2172621-overview
Jan 20th, 2023 - SAAG Interpretation The serum ascites albumin gradient (SAAG) is a formula used to assist in determining the etiology of ascites. Also see Medscape’s Ascites Albumin Gradient Calculator. The formula is below. SAAG = serum albumin – ascites albumin...
https://doi.org/10.1186/s12957-023-02890-5
World Journal of Surgical Oncology; Miura Y, Ashida R et. al.
Jan 17th, 2023 - Budd-Chiari syndrome (BCS) is a rare vascular disorder of the liver, and acute and secondary BCS is even rarer. A 62-year-old man with perihilar cholangiocarcinoma of Bismuth type IIIa underwent right hemi-hepatectomy with caudate lobectomy and pa...
Guidelines 1 results
https://doi.org/10.1016/j.clinre.2020.03.015
Clinics and Research in Hepatology and Gastroenterology; Coilly A, Potier P et. al.
Apr 7th, 2020 - Budd-Chiari syndrome.|2020|Coilly A,Potier P,Broué P,Kounis I,Valla D,|
Drugs 1 results see all →
Clinicaltrials.gov 8 results
https://clinicaltrials.gov/ct2/show/NCT03541057
Aug 26th, 2022 - We will include patients with vascular liver diseases, including portal vein thrombosis (PVT) Budd-Chiari Syndrome (BCS) Heredetary Hemorrhagic Teleangiectasia (HHT, or Osler-Rendu Disease) Noncirrhotic-portal hypertension (NCPH) and Porto-sinusoi...
https://clinicaltrials.gov/ct2/show/NCT05123326
Nov 17th, 2021 - Our proposed study is important for the following 4 reasons. SCTs cannot be used to demonstrate the thrombomodulin mediated normal thrombin generation in patients with liver disease, so the monitoring of such patient using global coagulation tests...
https://clinicaltrials.gov/ct2/show/NCT03717792
Oct 5th, 2021 - Background Vascular liver disorders (VALDI), including Budd-Chiari syndrome (BCS), non-cirrhotic vascular liver disorders (VLD) and idiopathic non-cirrhotic portal hypertension (INCPH) are rare diseases that mainly affect children and young adults...
https://clinicaltrials.gov/ct2/show/NCT04753151
Aug 25th, 2021 - In this study, only adult ASA III to IV patients (18 to 70 years old), scheduled for orthotopic liver transplantation at the Hospital de Clínicas de Porto Alegre, Santa Casa de Porto Alegre and at the Hospital das Clínicas of the Faculty of Medici...
https://clinicaltrials.gov/ct2/show/NCT02201485
Apr 23rd, 2019 - Budd-Chiari syndrome (BCS) is defined as the hepatic outflow obstruction from the small hepatic veins to the confluence between inferior vena cava and right atrium, which often leads to the life-threatening complications, such as liver failure and...
News 12 results
https://www.onclive.com/view/expert-highlights-advances-for-patients-with-pnh
Oct 6th, 2021 - According to Mohamed Kharfan-Dabaja, MD, there is ever-increasing hope for patients suffering from paroxysmal nocturnal hemoglobinuria (PNH), a rare disease characterized by the premature breakdown of blood cells that is caused by a somatic mutati...
https://www.onclive.com/view/selecting-appropriate-therapy-at-progression-of-pv
Apr 2nd, 2021 - Transcript: Harry P. Erba, MD, PhD: We have these therapies. We have hydroxyurea, phlebotomy, aspirin, and interferon in selected patients. How do we then describe, understand, or recognize the patient who has progression of their disease and ...
https://www.onclive.com/view/polycythemia-vera-diagnosis
Apr 2nd, 2021 - Transcript:Ruben Mesa, MD: The burden that a patient with polycythemia vera experiences is heterogeneous, but can be problematic. Our group has been very engaged in trying to quantify that burden. It includes many aspects. It includes the risk of ...
https://reference.medscape.com/viewarticle/893603_3
Mar 12th, 2018 - A meta-analysis revealed that probiotics have a clinical impact on patients with hepatic encephalopathy. Probiotic use was associated with improvements in management and decreased hospitalization rates; however, no impact on overall mortality rate...
https://www.mdedge.com/ccjm/article/132145/emergency-medicine/bleeding-esophageal-varices-who-should-receive-shunt?channel=312
Ghassoub Rifai, MD, Zade Akras et. al.
Mar 1st, 2017 - A transjugular intrahepatic portosystemic shunt (TIPS) has been shown in randomized controlled trials to be effective for: Secondary prevention of variceal bleeding Controlling refractory ascites in patients with liver cirrhosis. In addition, find.
